IBJNews

Lilly reports $942 million profit in third quarter

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. swung to a profit in its third quarter, the Indianapolis-based company reported this morning.

The company earned nearly $942 million, or 86 cents per share, compared with a loss of $466 million, or 43 cents per share, in the same quarter a year ago.

The year-ago loss resulted from Lilly's acquisition of New York-based ImClone Systems Inc. Assuming Lilly had owned ImClone for all of 2008, and excluding other extraordinary charges this year, the company would have earned $1.20 per share, an increase of 22 percent over the same quarter a year ago. On that basis, Wall Street analysts were expecting Lilly to earn $1.02 per share.

"Our performance in the third quarter once again was driven by volume-based sales growth, improving gross margins and tight control of operating expenses, allowing us to deliver very attractive earnings growth," said Lilly CEO John Lechleieter in a statement.

Lilly's revenue rose 7 percent in the quarter over the same period of 2008, to $5.56 billion.

Lilly's strongest drug was Alimta, which treats various stages of non-small cell lung cancer. Its sales grew 47 percent compared with the third quarter last year. The antidepressant Cymbalta and the insulin Humalog also posted double-digits sales growth in the third quarter.

Lilly recorded a charge of 23 cents per share because it agreed last week to sell its Tippecanoe Laboratories plant in Lafayette to a German firm. That charge, before taxes, consisted of a $355 million accounting charge and $38 million in cash that Lilly will pay out to its 700 employees at Tippecanoe as severance.

The company also took a charge to abandon two phase-3 products designed to treat osteoporosis and multiple sclerosis.

So far this year, Lilly has earned $2.31 per share, excluding a charge of 6 cents per share to settle lawsuits brought by various states alleging illegal marketing of Lilly's bestseller, Zyprexa.

The company has not been issuing quarterly profit forecasts. But, in July, it predicted it would earn $4.20 to $4.30 per share for the entire year.

Lilly's stock in the last month has jumped nearly 9 percent. But, for the year, its shares are still down 12.5 percent.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. I am also a "vet" of several Cirque shows and this one left me flat. It didn't have the amount of acrobatic stunts as the others that I have seen. I am still glad that I went to it and look forward to the next one but I put Varekai as my least favorite.

  2. Looking at the two companies - in spite of their relative size to one another -- Ricker's image is (by all accounts) pretty solid and reputable. Their locations are clean, employees are friendly and the products they offer are reasonably priced. By contrast, BP locations are all over the place and their reputation is poor, especially when you consider this is the same "company" whose disastrous oil spill and their response was nothing short of irresponsible should tell you a lot. The fact you also have people who are experienced in franchising saying their system/strategy is flawed is a good indication that another "spill" has occurred and it's the AM-PM/Ricker's customers/company that are having to deal with it.

  3. Daniel Lilly - Glad to hear about your points and miles. Enjoy Wisconsin and Illinois. You don't care one whit about financial discipline, which is why you will blast the "GOP". Classic liberalism.

  4. Isn't the real reason the terrain? The planners under-estimated the undulating terrain, sink holes, karst features, etc. This portion of the route was flawed from the beginning.

  5. You thought no Indy was bad, how's no fans working out for you? THe IRl No direct competition and still no fans. Hey George Family, spend another billion dollars, that will fix it.

ADVERTISEMENT